EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression

Mengna Wang, Yuhong Liu, Yanshi Li, Tao Lu, Min Wang, Zhaobo Cheng, Lin Chen, Tongling Wen, Min Pan, Guohua Hu iD

Advanced Science · 2025-02 · 12 (5)

DOI: 10.1002/advs.202405845 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 11.12.2024. Verfasst von Mengna Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, P. R. China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Indoleamine-Pyrrole 2,3,-Dioxygenase, Nanoparticles, Immunotherapy. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical efficacy of immune checkpoint blockade (ICB) therapy is significantly compromised in the metabolically disordered tumor microenvironment (TME), posing a formidable challenge that cannot be ignored in current antitumor strategies. In this study, TME‐responsive nanoparticles (HMP1G NPs) loaded with 1‐methyltryptophan (1‐MT; an indoleamine 2,3‐dioxygenase 1 [IDO1] inhibitor,) and S‐nitrosoglutathione (GSNO; a nitric oxide donor) is developed to enhance the therapeutic efficacy of 1‐MT‐mediated ICB. The HMP1G NPs responded to H + and glutathione in the TME, releasing Mn 2+ , GSNO, and 1‐MT. The released Mn 2+ catalyzed the production of abundant reactive oxygen species and nitric oxide from hydrogen peroxide and GSNO, and the generated nitric oxide, synergistically with 1‐MT, inhibited the accumulation of kynurenine mediated by IDO1 in the tumor. Mechanistically, HMP1G NPs downregulated tumor cell‐derived IDO1 via the aryl hydrocarbon receptor/signal transducer and activator of transcription 3/interleukin signaling axis to improve kynurenine/tryptophan metabolism and immunosuppression. In a murine breast cancer model, treatment with HMP1G NPs elicited effective antitumor immunity and enhanced survival outcomes. This study highlights a novel nano‐platform that simultaneously improves metabolism and enhances ICB efficacy to achieve a new and efficient antitumor strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentIndoleamine-Pyrrole 2,3,-DioxygenaseNanoparticlesImmunotherapyAnimalsMiceTryptophanFemaleCell Line, TumorHumansMice, Inbred BALB CImmunosuppression Therapy

Stichwörter der Autor:innen

KYN/TRP metabolismchemodymic therapyimmunosuppressionindoleamine 2,3‐dioxygenase 1

Substanzen

Indoleamine-Pyrrole 2,3,-DioxygenaseTryptophan1-methyltryptophanIDO1 protein, humanIDO1 protein, mouse

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, P. R. China.
  • The First Clinical College, Chongqing Medical University, Chongqing, 400016, P. R. China.

ORCID-Profile: Guohua Hu

Förderung

  • Innovative Research Group Project of the National Natural Science Foundation of China

Zitieren

APA

Wang, M., Liu, Y., Li, Y., Lu, T., Wang, M., Cheng, Z., Chen, L., Wen, T., Pan, M., & Hu, G. (2025). Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression. Advanced Science, 12(5). https://doi.org/10.1002/advs.202405845

Vancouver

Wang M, Liu Y, Li Y, Lu T, Wang M, Cheng Z, et al. Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression. Advanced Science. 2025;12(5). doi:10.1002/advs.202405845

BibTeX
@article{Wang2025,
  author = {Wang, Mengna and Liu, Yuhong and Li, Yanshi and Lu, Tao and Wang, Min and Cheng, Zhaobo and Chen, Lin and Wen, Tongling and Pan, Min and Hu, Guohua},
  title = {Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {5},
  doi = {10.1002/advs.202405845}
}
Kostenlos starten →